Sphera Funds Management Ltd. Vigil Neuroscience, Inc. Transaction History
Sphera Funds Management Ltd.
- $545 Million
- Q3 2024
A detailed history of Sphera Funds Management Ltd. transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 1,647,604 shares of VIGL stock, worth $2.8 Million. This represents 1.03% of its overall portfolio holdings.
Number of Shares
1,647,604
Previous 1,692,166
2.63%
Holding current value
$2.8 Million
Previous $6.77 Million
17.24%
% of portfolio
1.03%
Previous 0.99%
Shares
4 transactions
Others Institutions Holding VIGL
# of Institutions
53Shares Held
27.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$9.92 Million2.45% of portfolio
-
Northpond Ventures, LLC4.21MShares$7.16 Million51.65% of portfolio
-
Siren, L.L.C. New York, NY1.99MShares$3.38 Million0.34% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$3.08 Million0.2% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.6MShares$2.72 Million0.01% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $48.1M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...